New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia. - Wikidata - awgldk - TriplyDB

New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.

New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.

http://www.wikidata.org/entity/Q34616680

about

Role of apolipoprotein E in neurodegenerative diseases Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia The earlier the better: Alzheimer's prevention, early detection, and the quest for pharmacological interventions.

P2860

Q26799413-8FCCDEEA-5A9C-49BD-A8CB-7BDB10CE3DF7 Q35194099-0D3A5E12-D75E-4B59-906C-905D9D07521A Q35577335-8DAEDC5E-EECE-4BA0-BE6B-64C34EDFFC4A Q48082005-7716A2E6-E14D-4652-8D26-1117481361BB

P2860

New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.

http://www.wikidata.org/entity/Q34616680

description

1984 nî lūn-bûn

@nan

1984 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1984 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1984年の論文

@ja

1984年論文

@yue

1984年論文

@zh-hant

1984年論文

@zh-hk

1984年論文

@zh-mo

1984年論文

@zh-tw

1984年论文

@wuu

name

New mutants of apolipoprotein ...... type III hyperlipoproteinemia.

@ast

New mutants of apolipoprotein ...... type III hyperlipoproteinemia.

@en

New mutants of apolipoprotein ...... type III hyperlipoproteinemia.

@nl

type

label

New mutants of apolipoprotein ...... type III hyperlipoproteinemia.

@ast

New mutants of apolipoprotein ...... type III hyperlipoproteinemia.

@en

New mutants of apolipoprotein ...... type III hyperlipoproteinemia.

@nl

prefLabel

New mutants of apolipoprotein ...... type III hyperlipoproteinemia.

@ast

New mutants of apolipoprotein ...... type III hyperlipoproteinemia.

@en

New mutants of apolipoprotein ...... type III hyperlipoproteinemia.

@nl

P1433

Q34616680-3D76BED8-998A-4FD7-B814-702A07BF6F35

P1476

Q34616680-CA9C0C16-AC09-419B-B3B5-8C8BB5CBC812

P2093

Q34616680-4B1AC5D0-745D-4207-8DE5-16B11C7E09BA

Q34616680-4F847C50-30B3-4B6E-B740-179160A1B87A

Q34616680-5A191906-AC33-482B-870C-2CBA1F022AE9

Q34616680-6AF36FEB-3448-4693-B411-DA9FADAF4461

Q34616680-8B194980-64DE-497C-BE59-1D8FB390244D

Q34616680-CF2AA38F-1F27-41E9-BB53-C70C48BBC85A

P2860

Q34616680-1A6BCB6A-CEA1-40DD-92F0-1353929A77EB

Q34616680-455E8901-E9C1-4597-813D-E0F3637D7F53

Q34616680-4C690ED9-47E7-4715-BB7D-297962D66506

Q34616680-4ECBB275-3B00-4C7F-859B-C89F790B0AE0

Q34616680-6E4A94C7-C96A-41DC-84E7-67E62CE3029A

Q34616680-8DB08DCF-F2FE-4EB1-AB45-3D57C01C6CC3

Q34616680-91EB8A2F-3D76-4087-B561-5663E6A720F9

Q34616680-96700B6F-AC91-431D-BE58-B4C1A1D83470

Q34616680-97EB3C8B-208D-445B-AEDE-8ADAA0E513C2

Q34616680-A77CE2CE-4324-4370-A13C-CFC185C30263

P304

Q34616680-EC954A26-A54E-4025-B100-326525430E47

P31

Q34616680-35F9D5A8-8157-4E28-B35B-5C9B70FFF4D6

P356

Q34616680-95BECC28-0593-4EDB-B72F-0F48C1F3C177

P407

Q34616680-B2BEA593-BA7F-4A33-A0BF-9D479B3CBBFB

P433

Q34616680-0D8D718E-71DB-4FB6-96D8-615FB67B3B48

P478

Q34616680-60B941C0-C2A8-4EBA-AC39-C8DE8D50D04E

P577

Q34616680-4E04F9F6-5A7A-4962-BB8B-7E480ED123F3

P698

Q34616680-4A6D8C8C-CB88-4FA1-9DA6-2CD3A503A971

P921

Q34616680-75A3A081-9900-4C2C-B77B-AA36CF1144DD

P932

Q34616680-D9E21BBB-5CFF-4F9F-972F-2744B72E6CDC

P356

P1433

Journal of Clinical Investigation

P1476

New mutants of apolipoprotein ...... type III hyperlipoproteinemia.

@en

P2093

Hiramori K

http://www.w3.org/2001/XMLSchema#string

Nambu S

http://www.w3.org/2001/XMLSchema#string

Nishioeda Y

http://www.w3.org/2001/XMLSchema#string

Sumiyoshi T

http://www.w3.org/2001/XMLSchema#string

Yamamoto A

http://www.w3.org/2001/XMLSchema#string

Yamamura T

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

High resolution two-dimensional electrophoresis of proteins

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site

The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis

Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency.

Genetics of the apolipoprotein E system in man

Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.

Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype

Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.

P304

1229-1237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI111532

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

1984-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6480826

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

425289

http://www.w3.org/2001/XMLSchema#string